A serum-based ELISA for ZNF346, ZNF638, ZNF700 and ZNF768 was developed and autoantibodies to individual antigens were detected in 10–20% of CRC patients and in 0–5.7% NCCs. Here, ZNF346 is linked to colorectal carcinoma.